Chiharu Kawakami
Overview
Explore the profile of Chiharu Kawakami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takashita E, Shimizu K, Kawakami C, Momoki T, Saikusa M, Ozawa H, et al.
Immun Inflamm Dis
. 2025 Mar;
13(3):e70176.
PMID: 40071746
Background: COVID-19, caused by SARS-CoV-2, was first documented in Japan in January 2020. We previously reported an increased risk of rhinovirus infections among children during the early phase of the...
2.
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M, Tsumura Y, et al.
Vaccine
. 2024 Aug;
42(23):126241.
PMID: 39178768
Background: The annual administration of the influenza vaccine is the most effective method for preventing influenza. We have evaluated the effectiveness of the inactivated influenza vaccine in children aged 6 ...
3.
Shimizu K, Kawakami C, Matsuzaki Y, Fujisaki S, Nagata S, Morita H, et al.
Influenza Other Respir Viruses
. 2024 Jun;
18(6):e13345.
PMID: 38923307
Background: Influenza viruses can cause zoonotic infections that pose public health risks. Surveillance of influenza A and B viruses is conducted globally; however, information on influenza C and D viruses...
4.
Miyake S, Kato H, Tanaka N, Shimizu K, Ozawa H, Kawakami C, et al.
Front Public Health
. 2022 Feb;
9:690006.
PMID: 35155329
Background: Epidemiological contact tracing is a powerful tool to rapidly detect SARS-CoV-2 infection in persons with a close contact history with COVID-19-affected patients. However, it remains unclear whom and when...
5.
Numasawa M, Nawa N, Funakoshi Y, Noritake K, Tsuruta J, Kawakami C, et al.
PLoS One
. 2021 Jul;
16(7):e0255086.
PMID: 34293058
Background: Interprofessional education (IPE) is crucial in dentistry, medicine, and nursing. However, scant mixed methods studies have compared the IPE outcomes across these disciplines to develop evidence-based IPE. This study...
6.
Funabashi R, Miyakawa K, Yamaoka Y, Yoshimura S, Yamane S, Jeremiah S, et al.
J Mol Cell Biol
. 2021 Jun;
13(10):763-766.
PMID: 34165565
No abstract available.
7.
Yamaoka Y, Miyakawa K, Jeremiah S, Funabashi R, Okudela K, Kikuchi S, et al.
Cell Rep Med
. 2021 May;
2(6):100311.
PMID: 34027498
The ongoing coronavirus disease 2019 (COVID-19) pandemic is a major global public health concern. Although rapid point-of-care testing for detecting viral antigen is important for management of the outbreak, the...
8.
Shinjoh M, Sugaya N, Yamaguchi Y, Ookawara I, Nakata Y, Narabayashi A, et al.
PLoS One
. 2021 Mar;
16(3):e0249005.
PMID: 33770132
During influenza epidemics, Japanese clinicians routinely conduct rapid influenza diagnostic tests (RIDTs) in patients with influenza-like illness, and patients with positive test results are treated with anti-influenza drugs within 48...
9.
Takashita E, Kawakami C, Momoki T, Saikusa M, Shimizu K, Ozawa H, et al.
Influenza Other Respir Viruses
. 2021 Mar;
15(4):488-494.
PMID: 33715290
Background: Coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in Japan in January 2020 and has spread throughout the country. Previous...
10.
Mitamura K, Yamazaki M, Ichikawa M, Yasumi Y, Shiozaki K, Tokushima M, et al.
J Infect Chemother
. 2020 Nov;
27(3):450-454.
PMID: 33218876
Introduction: ID NOW™ Influenza A & B 2 (ID NOW 2) is a rapid molecular assay that combines two characteristics, namely the rapidness of rapid antigen detection test (RADT) and...